首页> 外文期刊>Clinical, Cosmetic and Investigational Dermatology >Cohesive Polydensified Matrix? hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds
【24h】

Cohesive Polydensified Matrix? hyaluronic acid volumizer injected for cheek augmentation has additional positive effect on nasolabial folds

机译:内聚性增稠的基质?透明质酸丰盈剂注射可增加脸颊皱纹,对鼻唇沟有额外的积极作用

获取原文
           

摘要

Purpose: Cohesive Polydensified Matrix? hyaluronic acid (CPM-HA) volumizer has been used successfully for several years to reverse biometric volume loss during facial aging. This observational study explored the additive effect on nasolabial folds when CPM-HA volumizer is injected into the neighboring cheek area. Patients and methods: In this open-label, prospective, postmarketing noninterventional study, 18 adult patients seeking esthetic enhancement of the lateral cheek hollows and cheekbone area were injected with CPM-HA volumizer integrated with lidocaine (CPM-HA-VL) in the upper or lower cheek area. Safety and performance of CPM-HA-VL up to 12 months after injection with follow-up visits at week 4 and month 3, 6, and 12 were assessed. The primary endpoint was improvement of cheek fullness on the validated Merz Aesthetics Scales. Additionally, changes in nasolabial folds were quantified using a phaseshift rapid in vivo measurement of skin optical three-dimensional (3D) in vivo measurement device. Results: Patients (94.4% female, median age 52 years, age range 39–69 years) were injected with a mean volume of 2.5±1.1 mL CPM-HA-VL per side. Immediately after injection, mean severity for upper and lower cheek fullness assessed on the validated MAS improved from 2.5±0.6 and 2.8±0.5, respectively, to 1.0±0.0, and remained unchanged through month 12. Improvement in relation to baseline was attested on the Global Aesthetics Improvement Scale for all assessments. Compared with baseline, the following assessments offered a statistical significance in the reduction of wrinkle depth of nasolabial folds (maximum depth reduction by 30.4% at 3 months) according to optical 3D in vivo measurements. Pain during injection was minimal and abated within 30 minutes. Treatment was well tolerated and led to great patient satisfaction. Conclusion: CPM-HA-VL injected into the upper and lower cheeks led to long-lasting satisfactory cosmetic results in cheek augmentation as well as in reducing depth of nasolabial folds adjacent to the injection site.
机译:目的:内聚性增稠基质透明质酸(CPM-HA)丰盈剂已成功使用数年,以逆转面部衰老过程中的生物特征量损失。这项观察性研究探讨了将CPM-HA丰盈剂注入邻近的脸颊区域时对鼻唇沟的累加作用。患者和方法:在这项开放性,前瞻性,上市后的非干预性研究中,对18位寻求美学增强侧颊凹窝和che骨区域的成年患者,在其上部注射了CPM-HA蓄积器并加利多卡因(CPM-HA-VL)或较低的脸颊区域。评估了注射后12个月内CPM-HA-VL的安全性和性能,并在第4周以及第3、6和12个月进行了随访。主要终点是在经过验证的梅尔兹美学量表上改善脸颊丰满度。另外,使用皮肤光学三维(3D)体内测量设备的相移快速体内测量来量化鼻唇沟的变化。结果:患者(每侧女性的平均年龄为94.4%,中位年龄为52岁,年龄范围为39-69岁)注射量为2.5±1.1 mL CPM-HA-VL。注射后立即,通过验证的MAS评估的上颊和下颊丰满度的平均严重程度分别从2.5±0.6和2.8±0.5改善至1.0±0.0,并在第12个月保持不变。所有评估的全球美学改善量表。与基线相比,根据光学3D体内测量,以下评估在减少鼻唇沟皱纹深度(3个月最大深度减少30.4%)方面具有统计学意义。注射期间的疼痛极小,并在30分钟内减轻。治疗耐受性良好,使患者感到非常满意。结论:将CPM-HA-VL注射到上颊和下颊可导致持久的令人满意的美容效果,可增强脸颊,并减少邻近注射部位的鼻唇沟的深度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号